| Metric | Value (₹ Cr) | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue | 65.97 | 14.2% | 4.3% |
| Total Income | 67.31 | 12.8% | 10.5% |
| Expenditure | 80.35 | 9.9% | 5.2% |
| PBT | -18.34 | 546.4% | 1519.9% |
| Net Profit | -16.76 | 1109.7% | 282.5% |
| OPM | 3.24% | 30.11pp | 21.12pp |
| NPM | -24.90% | 27.05pp | 19.07pp |
| EPS | 1.38 | 885.7% | 213.6% |
Virinchi Ltd FY26: Revenue Up 19.53% YoY to ₹183.38 Cr, PAT at ₹13.98 Cr
31 May 2026 · 31 May, 5:03 pm
Summary
Virinchi Limited reported mixed financial outcomes for Q4 and the full fiscal year ended March 31, 2026. Standalone revenue saw a healthy 19.53% year-on-year growth to ₹183.38 crore for FY26, primarily driven by strong performances in its SaaS and ITES segments. However, a significant one-time write-off of ₹8.43 crore on a receivable during Q4FY26 substantially impacted profitability, resulting in a 12.85% decline in standalone PAT to ₹13.98 crore and a consolidated net loss of ₹27.39 crore for the year. Despite these reported declines, management emphasized the robust underlying operating performance of its core businesses. The company expressed optimism for FY27, expecting a turnaround in healthcare performance and positioning itself for a return to profitable growth.
Key Highlights
- 1
Virinchi Limited reported standalone revenue of ₹183.38 crore for FY26, marking a 19.53% increase year-on-year, primarily propelled by growth in the SaaS and ITES businesses.
- 2
Standalone Profit After Tax (PAT) for FY26 declined by 12.85% to ₹13.98 crore, predominantly due to a one-time write-off of ₹8.43 crore on a receivable from QC Holdings in Q4FY26.
- 3
On a consolidated basis, the Group's revenue for FY26 stood at ₹286.13 crore, accompanied by a negative PAT of ₹27.39 crore, significantly impacted by the aforementioned write-off.
- 4
The SaaS business demonstrated robust performance, with full-year revenue growing by 15.42% to ₹153.94 crore, benefiting from stable recurring revenue streams from recently acquired clients.
- 5
IDC & IT Services revenue experienced a decline of 29.55% year-on-year to ₹40.37 crore for FY26, attributed to a stricter U.S. visa regime and a strategic shift towards offshore delivery models.
- 6
In March 2026, the promoter acquired a 49% stake in Virinchi Health Care Private Limited through a fresh infusion of funds, transitioning it from a wholly-owned to a significant subsidiary.
- 7
Management anticipates the company to be structurally stronger and well-positioned for a return to profitable growth in FY27, despite the one-time write-off impacting current year profitability.
Informational and educational content only. Not investment advice.